On July 21, 2026 Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, reported that members of its management team will participate in the BTIG Virtual Biotechnology Conference taking place virtually July 28, 2026.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
BTIG Biotechnology Conference 2026
Date: Tuesday, July 28, 2026
Format: 1×1 Meetings
Location: Virtual
Institutional Investors interested in meeting with Vaxart management should contact their BTIG representative.
(Press release, Vaxart, JUL 21, 2026, View Source [SID1234669361])